FBO#3972
A - Research and Development
AWARDS - October 9, 2012
- HHSN272201200032C - $6,501,809 (Base Period) Not to exceed $17,074,553 (Options)
VACCINE TECHNOLOGIES TO ADVANCE NEXT GENERATION ANTHRAX VACCINES
Health Protection Agency, Porton Down,<br />, Salisbury, Wiltshire<br />, SP4 0JG, United Kingdom, ,, United Kingdom
- HHSN272201200034C - $1,760,014 (Base Period) Not to exceed $8,192,557 (Options)
VACCINE TECHNOLOGIES TO ADVANCE NEXT GENERATION ANTHRAX VACCINES
Fraunhofer USA Center for Molecular Biotechnology, 9 Innovation Way, Newark, Delaware 19711, United States
- HHSN272201200033C - $2,180,144 (Base Period) Not to exceed $20,729,822 (Options)
VACCINE TECHNOLOGIES TO ADVANCE NEXT GENERATION ANTHRAX VACCINES
Pfenex, Inc., 10790 Roselle Street, San Diego, California 92121, United States
| This Issue's Index | Today's FBO Daily Index Page |
Created on 07-Oct-2012 by Loren Data Corp. -- info@fbodaily.com